173 related articles for article (PubMed ID: 1831802)
1. Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Int J Cancer; 1991 Sep; 49(2):186-90. PubMed ID: 1831802
[TBL] [Abstract][Full Text] [Related]
2. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Int J Cancer; 1991 Sep; 49(2):191-5. PubMed ID: 1831803
[TBL] [Abstract][Full Text] [Related]
3. Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Int J Cancer; 1991 Sep; 49(2):182-5. PubMed ID: 1831801
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer and depot-medroxyprogesterone acetate: a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Lancet; 1991 Oct; 338(8771):833-8. PubMed ID: 1681212
[TBL] [Abstract][Full Text] [Related]
5. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Contraception; 1992 Apr; 45(4):299-312. PubMed ID: 1387601
[TBL] [Abstract][Full Text] [Related]
6. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
7. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Ray RM
Contraception; 1995 Nov; 52(5):307-12. PubMed ID: 8585888
[TBL] [Abstract][Full Text] [Related]
8. Invasive cervical cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Noonan L; Whitehead A; Roseman D
Bull World Health Organ; 1985; 63(3):505-11. PubMed ID: 2931205
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Noonan L; Whitehead A
Bull World Health Organ; 1985; 63(3):513-9. PubMed ID: 2931206
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica.
Oberle MW; Rosero-Bixby L; Irwin KL; Fortney JA; Lee NC; Whatley AS; Bonhomme MG
Int J Epidemiol; 1988 Dec; 17(4):718-23. PubMed ID: 2976059
[TBL] [Abstract][Full Text] [Related]
11. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
[TBL] [Abstract][Full Text] [Related]
12. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
13. A case-control study of breast cancer and hormonal contraception in Costa Rica.
Lee NC; Rosero-Bixby L; Oberle MW; Grimaldo C; Whatley AS; Rovira EZ
J Natl Cancer Inst; 1987 Dec; 79(6):1247-54. PubMed ID: 2961909
[TBL] [Abstract][Full Text] [Related]
14. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation.
Pardthaisong T; Yenchit C; Gray R
Contraception; 1992 Apr; 45(4):313-24. PubMed ID: 1387602
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature.
Simbar M; Tehrani FR; Hashemi Z; Zham H; Fraser IS
J Fam Plann Reprod Health Care; 2007 Oct; 33(4):271-6. PubMed ID: 17925114
[TBL] [Abstract][Full Text] [Related]
16. Steroid contraceptive use and pregnancy outcome.
Pardthaisong T; Gray RH; McDaniel EB; Chandacham A
Teratology; 1988 Jul; 38(1):51-8. PubMed ID: 2845595
[TBL] [Abstract][Full Text] [Related]
17. International forum update: depot medroxyprogesterone acetate and endometrial carcinoma.
McDaniel EB; Potts M
Int J Gynaecol Obstet; 1979; 17(3):297-9. PubMed ID: 42591
[TBL] [Abstract][Full Text] [Related]
18. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
19. Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge.
Chilvers CE
Drug Saf; 1996 Sep; 15(3):212-8. PubMed ID: 8879975
[TBL] [Abstract][Full Text] [Related]
20. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
Dahlberg K
Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
